NFKB1 and acute pancreatitis: Bone marrow-derived mesenchymal stem cells deliver miR-9, which targets the NF-κB1/p50 gene, to the damaged pancreas or peripheral blood mononuclear cells, possibly attenuating severe acute pancreatitis (20).